 |
Quit-smoking drug 'raises heart risks'Healthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs on the market, have a higher risk of suffering heart attacks or other serious heart problems, a study said. British and American More… |
Thursday 26 December 2024
